「nov」の検索結果
22件：16～20件目を表示
-
Milestones in Our History | About Senju | SENJU Pharmaceutical
t for manufacturing established in Kanzaki-gun, Hyogo June Shoji Yoshida became the President. 1978 November Company head office relocated in Hiranomachi, Higashi-ku, Osaka. 1980 February Ophthalmic S...
https://www.senju.co.jp/english/about/history.html -
お知らせ | 千寿製薬株式会社
April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approv...
https://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
April 6, 2026 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） December 22, 2025 Obtained manufacturing and marketing approv...
http://www.senju.co.jp/english/news/ -
お知らせ | 千寿製薬株式会社
2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Ja...
http://www.senju.co.jp/chinese/news/ -
お知らせ | 千寿製薬株式会社
2026年04月06日 Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition（PDF） 2025年12月22日 Obtained manufacturing and marketing approval in Ja...
https://www.senju.co.jp/chinese/news/